Regulatory obstacles unlikely for Ebos' A$1.17b LifeHealthcare purchase

Regulatory obstacles unlikely for Ebos' A$1.17b LifeHealthcare purchase
Ebos CEO John Cullity doesn't want to pre-empt regulators. (Image: supplied)
Jenny Ruth
Ebos Group's purchase of the LifeHealthcare business is unlikely to have trouble clearing competition watchdogs on either side of the Tasman since its existing medical devices business is quite small.Ebos bought the LMT and National Surgical businesses in late 2019 for A$34 million compared with the LifeHealthcare purchase price of A$1.17 billion.In August last year, it also announced the purchase of Pioneer Medical, a New Zealand-based importer and distributor of spine and major joint implants and associated surgical technologies.Ebos didn...

More Infrastructure

Auckland housing project withdrawn from fast-track
Policy

Auckland housing project withdrawn from fast-track

The developer plans to lodge a fresh application after draft decline.

150 years of infrastructure spending going ‘boom’
Infrastructure

150 years of infrastructure spending going ‘boom’

We actually spend a lot more on infrastructure than you might think.

Construction suicide costs at $1.3 billion
Infrastructure

Construction suicide costs at $1.3 billion

A survey found that almost one in five workers reported suicidal thoughts.

Chido Machingura 12 Sep 2025
F&P Healthcare one step closer to new Karaka campus
Policy

F&P Healthcare one step closer to new Karaka campus

Auckland Council has approved a request to rezone nearly 90ha going to hearings.

Oliver Lewis 12 Sep 2025